Journal of Parkinson's Disease, 1877-718X

Journal

More filtering options
  1. 2020
  2. Animal Models of Parkinson's Disease: Are They Useful or Not?

    Roger A Barker & Anders Björklund, 2020 Jul 21, In : Journal of Parkinson's Disease.

    Research output: Contribution to journalReview article

  3. BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia

    Simona Scheggi, Francesca Rossi, Sara Corsi, Silvia Fanni, Elisabetta Tronci, Congiu Ludovica, Romina Vargiu, Carla Gambarana, Ana Muñoz, Roberto Stancampiano, Anders Björklund & Manolo Carta, 2020 Jul 8, In : Journal of Parkinson's Disease.

    Research output: Contribution to journalArticle

  4. Protein Quality Control Pathways at the Crossroad of Synucleinopathies

    Eduardo P. De Mattos, Anne Wentink, Carmen Nussbaum-Krammer, Christian Hansen, Steven Bergink, Ronald Melki & Harm H. Kampinga, 2020 Apr 3, In : Journal of Parkinson's Disease. 10, 2, p. 369-382 14 p.

    Research output: Contribution to journalReview article

  5. Delayed Clinical Manifestation of Parkinson's Disease among Physically Active: Do Participants in a Long-Distance Ski Race Have a Motor Reserve?

    Tomas T. Olsson, Martina Svensson, Ulf Hållmarker, Stefan James & Tomas Deierborg, 2020, In : Journal of Parkinson's Disease. 10, 1, p. 267-274 8 p.

    Research output: Contribution to journalArticle

  6. GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop

    Roger A. Barker, Anders Björklund, Don M. Gash, Alan Whone, Amber Van Laar, Jeffrey H. Kordower, Krystof Bankiewicz, Karl Kieburtz, Mart Saarma, Sigrid Booms, Henri J. Huttunen, Adrian P. Kells, Massimo S. Fiandaca, A. Jon Stoessl, David Eidelberg, Howard Federoff, Merja H. Voutilainen, David T. Dexter, Jamie Eberling, Patrik Brundin & 11 others, Lyndsey Isaacs, Leah Mursaleen, Eros Bresolin, Camille Carroll, Alasdair Coles, Brian Fiske, Helen Matthews, Codrin Lungu, Richard K. Wyse, Simon Stott & Anthony E. Lang, 2020, In : Journal of Parkinson's Disease. 10, 3, p. 875-891 17 p.

    Research output: Contribution to journalArticle

  7. Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial

    Adrianus L.A.J. Hommel, Marjan J. Meinders, Nico J. Weerkamp, Carmen Richinger, Christian Schmotz, Stefan Lorenzl, Richard Dodel, Miguel Coelho, Joaquim J. Ferreira, Francois Tison, Thomas Boraud, Wassilios G. Meissner, Kristina Rosqvist, Jonathan Timpka, Per Odin, Michael Wittenberg, Bas R. Bloem, Raymond T. Koopmans, Anette Schragand & Care of Late Stage Parkinsonism (CLaSP) Consortium Care of Late Stage Parkinsonism (CLaSP) Consortium, 2020, In : Journal of Parkinson's Disease. 10, 3, p. 1171-1184 14 p.

    Research output: Contribution to journalArticle

  8. 2019
  9. 2018
  10. Dopaminergic effect on non-motor symptoms in late stage Parkinson's disease

    Kristina Rosqvist, Per Odin, Peter Hagell, Susanne Iwarsson, Maria H. Nilsson & Alexander Storch, 2018 Jul 5, In : Journal of Parkinson's Disease. 8, 3, p. 409-420 12 p.

    Research output: Contribution to journalArticle

  11. Continuous drug delivery aiming continuous dopaminergic stimulation in Parkinson's disease

    Daniel J. Van Wamelen, Sotirios Grigoriou, K. Ray Chaudhuri & Per Odin, 2018, In : Journal of Parkinson's Disease. 8, s1, p. S65-S72

    Research output: Contribution to journalReview article

  12. Levodopa effect and motor function in late stage Parkinson's disease

    Kristina Rosqvist, Malcolm Horne, Peter Hagell, Susanne Iwarsson, Maria H. Nilsson & Per Odin, 2018, In : Journal of Parkinson's Disease. 8, 1, p. 59-70 12 p.

    Research output: Contribution to journalArticle

  13. Repairing the brain: Gene therapy

    Tomas Björklund, 2018, In : Journal of Parkinson's Disease. 8, s1, p. S123-S130

    Research output: Contribution to journalReview article

  14. Repairing the brain: Cell replacement using stem cell-based technologies

    Claire Henchcliffe & Malin Parmar, 2018, In : Journal of Parkinson's Disease. 8, s1, p. S131-S137

    Research output: Contribution to journalReview article

  15. 2017
  16. Factors Contributing to Perceived Walking Difficulties in People with Parkinson’s Disease

    Manzur Kader, Susann Ullén, Susanne Iwarsson, Per Odin & Maria H Nilsson, 2017 May 16, In : Journal of Parkinson's Disease. 7, 2, p. 397–407 11 p.

    Research output: Contribution to journalArticle

  17. A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement

    Paul De Roos, Bastiaan R. Bloem, Thomas A. Kelley, Angelo Antonini, Richard Dodel, Peter Hagell, Connie Marras, Pablo Martinez-Martin, Shyamal H. Mehta, Per Odin, Kallol Ray Chaudhuri, Daniel Weintraub, Bil Wilson & Ryan J. Uitti, 2017, In : Journal of Parkinson's Disease. 7, 3, p. 533-543 11 p.

    Research output: Contribution to journalArticle

  18. Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines

    Filip Ventorp, Cecilie Bay-Richter, Analise Sauro Nagendra, Shorena Janelidze, Viktor Sjödahl Matsson, Jack Lipton, Ulrika Nordström, Asa Westrin, Patrik Brundin & Lena Brundin, 2017, In : Journal of Parkinson's Disease. 7, 2, p. 263-273 11 p.

    Research output: Contribution to journalArticle

  19. Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease

    Thomas Willows, Nil Dizdar, Dag Nyholm, Håkan Widner, Peter Grenholm, Ursula Schmiauke, Anna Urbom, Kristina Groth, Jörgen Larsson, Johan Permert & Susanna Kjellander, 2017, In : Journal of Parkinson's Disease. 7, 4, p. 719-728 10 p.

    Research output: Contribution to journalArticle

  20. Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?

    Anders Björklund & Olle Lindvall, 2017, In : Journal of Parkinson's Disease. 7, s1, p. S23-S33

    Research output: Contribution to journalReview article

  21. 2016
  22. Impulse Control Disorders: The Continuum Hypothesis

    Georg Stenberg, 2016 Mar 30, In : Journal of Parkinson's Disease. 6, 1, p. 67-75 9 p.

    Research output: Contribution to journalArticle

  23. Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection

    Diane M A Swallow, Michael A Lawton, Katherine A Grosset, Naveed Malek, Callum R Smith, Nin P Bajaj, Roger A Barker, Yoav Ben-Shlomo, David J Burn, Thomas Foltynie, John Hardy, Huw R Morris, Nigel Williams, Nicholas W Wood, Donald G Grosset & PRoBaND Clinical Consortium PRoBaND Clinical Consortium, 2016 Mar 19, In : Journal of Parkinson's Disease. 6, 2, p. 289-300 12 p.

    Research output: Contribution to journalArticle

  24. Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?

    Roger A Barker, Malin Parmar, Agnete Kirkeby, Anders Björklund, Lachlan Thompson & Patrik Brundin, 2016, In : Journal of Parkinson's Disease. 6, 1, p. 57-63 7 p.

    Research output: Contribution to journalArticle

  25. Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.

    Daniel Lindqvist, Inga Prokopenko, Elisabet Londos, Lefkos Middleton & Oskar Hansson, 2016, In : Journal of Parkinson's Disease. 6, 1, p. 99-108

    Research output: Contribution to journalArticle

  26. Health and social service access among family caregivers of people with Parkinson's disease

    Yvonne Olsson, Lena Clarén, Anette Alvariza, Kristofer Årestedt & Peter Hagell, 2016, In : Journal of Parkinson's Disease. 6, 3, p. 581-587 7 p.

    Research output: Contribution to journalArticle

  27. 2015
  28. Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?

    Alison J Yarnall, Rachael A Lawson, Gordon W Duncan, David P Breen, Tien K Khoo, David Brooks, Roger A Barker, John-Paul Taylor & David J Burn, 2015, In : Journal of Parkinson's Disease. 5, 4, p. 743-7 5 p.

    Research output: Contribution to journalArticle

  29. Barriers and Facilitators for Participation in People with Parkinson's Disease

    Maria H Nilsson, Susanne Iwarsson, Björg Thordardottir & Maria Haak, 2015, In : Journal of Parkinson's Disease. 5, 4, p. 983-992

    Research output: Contribution to journalArticle

  30. Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson's Disease.

    Mareike Fauser, Matthias Löhle, Georg Ebersbach, Per Odin, Gerd Fuchs, Wolfgang H Jost, K Ray Chaudhuri, Rainer Koch & Alexander Storch, 2015, In : Journal of Parkinson's Disease. 5, 4, p. 737-741

    Research output: Contribution to journalArticle

  31. Tracking Parkinson's: Study Design and Baseline Patient Data

    Naveed Malek, Diane M A Swallow, Katherine A Grosset, Michael A Lawton, Sarah L Marrinan, Alexander C Lehn, Catherine Bresner, Nin Bajaj, Roger A Barker, Yoav Ben-Shlomo, David J Burn, Thomas Foltynie, John Hardy, Huw R Morris, Nigel M Williams, Nicholas Wood, Donald G Grosset & PRoBaND PRoBaND, 2015, In : Journal of Parkinson's Disease. 5, 4, p. 947-59 13 p.

    Research output: Contribution to journalArticle

  32. 2014
  33. Is Exenatide the Next Big Thing in Parkinson's Disease?

    Tanya Simuni & Patrik Brundin, 2014, In : Journal of Parkinson's Disease. 4, 3, p. 345-347

    Research output: Contribution to journalArticle

  34. Mild cognitive impairment and Parkinson's disease - something to remember

    Roger A Barker & Caroline H Williams-Gray, 2014, In : Journal of Parkinson's Disease. 4, 4, p. 651-6 6 p.

    Research output: Contribution to journalArticle

  35. Quality of life and mild cognitive impairment in early Parkinson's disease: does subtype matter?

    Rachael A Lawson, Alison J Yarnall, Gordon W Duncan, Tien K Khoo, David P Breen, Roger A Barker, Daniel Collerton, John-Paul Taylor & David J Burn, 2014, In : Journal of Parkinson's Disease. 4, 3, p. 331-6 6 p.

    Research output: Contribution to journalArticle

  36. The Significance of Walking from the Perspective of People with Parkinson's Disease.

    Catharina Sjödahl Hammarlund, Karolina E Andersson, Margareta Andersson, Maria H Nilsson & Peter Hagell, 2014, In : Journal of Parkinson's Disease. 4, 4, p. 657-663

    Research output: Contribution to journalArticle

  37. Which patients with Parkinson's disease participate in clinical trials? One centre's experiences with a new cell based therapy trial (TRANSEURO)

    Sarah F Moore, Natalie Valle Guzman, Sarah L Mason, Caroline H Williams-Gray & Roger A Barker, 2014, In : Journal of Parkinson's Disease. 4, 4, p. 671-6 6 p.

    Research output: Contribution to journalArticle

  38. 2013
  39. Linked clinical trials - the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments

    Patrik Brundin, Roger A Barker, P Jeffrey Conn, Ted M Dawson, Karl Kieburtz, Andrew J Lees, Michael A Schwarzschild, Caroline M Tanner, Tom Isaacs, Joy Duffen, Helen Matthews & Richard K H Wyse, 2013 Jan 1, In : Journal of Parkinson's Disease. 3, 3, p. 231-9 9 p.

    Research output: Contribution to journalArticle

  40. Bad News for Neuroprotective Therapies in PD?

    Angela Cenci Nilsson & David J Brooks, 2013, In : Journal of Parkinson's Disease. 3, 3, p. 271-273

    Research output: Contribution to journalDebate/Note/Editorial

  41. Discriminant capacity of four Fear of Falling rating scales in people with Parkinson's disease.

    Stina Jonasson, Jan Lexell & Maria H Nilsson, 2013, In : Journal of Parkinson's Disease. 3, S1, p. 165-165

    Research output: Contribution to journalPublished meeting abstract

  42. mTOR Inhibition Alleviates L-DOPA-Induced Dyskinesia in Parkinsonian Rats

    Mickael Decressac & Anders Björklund, 2013, In : Journal of Parkinson's Disease. 3, 1, p. 13-17

    Research output: Contribution to journalArticle

  43. Perceptions of participation among people with Parkinson's disease.

    Björg Thordardottir, Maria H Nilsson, Susanne Iwarsson & Maria Haak, 2013, In : Journal of Parkinson's Disease. 3, S1, p. 157-158

    Research output: Contribution to journalPublished meeting abstract

  44. Personality affects aspects of health-related quality of life in Parkinson's disease via psychological coping strategies

    Stephanie R Whitworth, Andrea M Loftus, Timothy C Skinner, Natalie Gasson, Roger A Barker, Romola S Bucks & Meghan G Thomas, 2013, In : Journal of Parkinson's Disease. 3, 1, p. 45-53 9 p.

    Research output: Contribution to journalArticle

  45. The relationship between abnormalities of saccadic and manual response times in Parkinson's disease

    Chrystalina A Antoniades, Zheyu Xu, R H S Carpenter & Roger A Barker, 2013, In : Journal of Parkinson's Disease. 3, 4, p. 557-63 7 p.

    Research output: Contribution to journalArticle

  46. 2012
  47. 2011
  48. Journal of Parkinson's Disease Introduction

    Patrik Brundin & J. William Langston, 2011, In : Journal of Parkinson's Disease. 1, 1, p. 1-1

    Research output: Contribution to journalDebate/Note/Editorial

  49. Measurement Properties of the SF-12 Health Survey in Parkinson's Disease

    Peter Hagell & Albert Westergren, 2011, In : Journal of Parkinson's Disease. 1, 2, p. 185-196

    Research output: Contribution to journalArticle

  50. Membrane Interaction of α-Synuclein in Different Aggregation States

    Marie Grey, Sara Linse, Hanna Nilsson, Patrik Brundin & Emma Sparr, 2011, In : Journal of Parkinson's Disease. 1, 4, p. 359-371

    Research output: Contribution to journalArticle

  51. Putaminal Upregulation of FosB/Delta FosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia

    Hanna Lindgren, Daniella Rylander, Hanna Iderberg, M. Andersson, S. S. O'Sullivan, D. R. Williams, A. J. Lees & Angela Cenci Nilsson, 2011, In : Journal of Parkinson's Disease. 1, 4, p. 347-357

    Research output: Contribution to journalArticle